Literature DB >> 23430715

Arthritis mutilans.

Amir Haddad1, Vinod Chandran.   

Abstract

Arthritis mutilans is described as the most severe form of psoriatic arthritis. It is characterized by digital shortening associated with severe osteolysis of peripheral joints. Research on arthritis mutilans has been impeded by lack of an accepted case definition. Here we describe the definitions used to date, epidemiology, clinical and radiological features, and clues to pathogenesis of arthritis mutilans. An initiative by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) to develop a consensus definition is described. The purpose of the GRAPPA initiative is to assist studies identifying clinical predictors and biomarkers for arthritis mutilans, so that patients at risk are identified early and appropriate therapeutic intervention is instituted to prevent joint destruction and preserve quality of life and function.

Entities:  

Mesh:

Year:  2013        PMID: 23430715     DOI: 10.1007/s11926-013-0321-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  30 in total

Review 1.  Juvenile rheumatoid arthritis.

Authors:  F Falcini; R Cimaz
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

2.  Psoriasis and arthritis.

Authors:  V WRIGHT
Journal:  Ann Rheum Dis       Date:  1956-12       Impact factor: 19.103

3.  Axial bone proliferation causing cervical myelopathy in the mutilans form of psoriatic arthritis despite peripheral bone erosion.

Authors:  J Ly; C Pinto; A Doyle; N Dalbeth; F M McQueen
Journal:  Ann Rheum Dis       Date:  2009-03       Impact factor: 19.103

4.  Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.

Authors:  Nicola Dalbeth; Bregina Pool; Timothy Smith; Karen E Callon; Maria Lobo; William J Taylor; Peter B Jones; Jillian Cornish; Fiona M McQueen
Journal:  Arthritis Res Ther       Date:  2010-08-26       Impact factor: 5.156

5.  Failure of small joint arthrodesis from resorption around a compression screw in a patient with lupus-associated arthritis mutilans: case report.

Authors:  Oluseyi Aliu; David T Netscher; Marcia Peltier
Journal:  Hand (N Y)       Date:  2007-10-09

6.  The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.

Authors:  A P Anandarajah; E M Schwarz; S Totterman; J Monu; C Y Feng; T Shao; S A Haas-Smith; C T Ritchlin
Journal:  Ann Rheum Dis       Date:  2007-10-29       Impact factor: 19.103

7.  The clinical spectrum of psoriatic arthritis.

Authors:  J M Moll
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176

8.  Predictors for radiological damage in psoriatic arthritis: results from a single centre.

Authors:  Simon J Bond; Vernon T Farewell; Catherine T Schentag; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2006-08-17       Impact factor: 19.103

9.  MRI bone oedema scores are higher in the arthritis mutilans form of psoriatic arthritis and correlate with high radiographic scores for joint damage.

Authors:  Yu M Tan; Mikkel Østergaard; Anthony Doyle; Nicola Dalbeth; Maria Lobo; Quentin Reeves; Elizabeth Robinson; William J Taylor; Peter B Jones; Karen Pui; Jamie Lee; Fiona M McQueen
Journal:  Arthritis Res Ther       Date:  2009-01-06       Impact factor: 5.156

View more
  3 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 2.  [Typical arthritis of the hands : Psoriatic arthritis].

Authors:  Matthias Bollow
Journal:  Radiologe       Date:  2021-03-30       Impact factor: 0.635

3.  Radiographic development during three decades in a patient with psoriatic arthritis mutilans.

Authors:  Leena Laasonen; Björn Gudbjornsson; Leif Ejstrup; Lars Iversen; Thomas Ternowitz; Mona Ståhle; Ulla Lindqvist
Journal:  Acta Radiol Open       Date:  2015-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.